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Abstract 
Decellularization of essential organs such as the lung has become an integral part of 
regenerative medicine. As the availability of donors is very low reseeding of these 
decellularized organs with a patient’s own cells is a potential therapy for those 
desperately in need. This way, the risks associated with allogeneic immune rejection are 
avoided. Some research groups have been successful in reseeding the lung with 
allogeneic differentiated cells. However, the barrier to presently overcome is to seed with 
stem cells and ensure these cells differentiate to all the desired cell types of the lung. 
Another obstacle is obtaining the desired number of cells for recellularization of large 
organs such as the lung. Scale-up methods using stirred vessel bioreactors with 
conditions similar to the physiological environment are a desirable alternative to 
conventional cell culture. In this study, I demonstrate large-scale cell culture in stirred 
flask bioreactors by facing the challenges of scale-up from 2D to 3D suspension culture. I 
also show the existence of exosomes in decellularized pig and mouse lung and identify 
the miRNAs (miRNAs) contained within them. MicroRNAs are becoming increasingly 
popular research tools as they are known to regulate many essential processes. Exosomes 
are enriched with miRNAs and can be shuttled between cells, thereby affecting target cell 
behavior.  I utilized the exosomes from decellularized lungs in directed differentiation of 
induced pluripotent stem cells (iPSCs) to the definitive endoderm (DE) lineage and 
compared it with conventional differentiation methods. The exosomes had a profound 
effect on the morphology of the cells which will lead to further studies on exosome-
directed differentiation procedures. 
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Introduction 
Lung tissue engineering is one of the least studied tissue engineering fields. The lung is a 
very large, complex organ with many cell types that have various functions. The demand 
for lungs is high and the waiting list for lung transplants is long. Therefore, there is an 
urgent need for the engineered organ. One way to potentially regenerate large organs is to 
decellularize them, leaving the extracellular matrix with the correct structure and 
molecular cues still present. The aim is to inject autologous induced pluripotent stem 
cells (iPSCs) or lung progenitors into the matrix so that the cells will be able to 
proliferate and differentiate in the right environment. iPSCs are differentiated cells that 
are reprogrammed to pluripotent stem cells which have the capability to differentiate into 
all cell types (Takahashi et al., 2007). Their applications are vast and I hypothesized that 
when iPSCs or iPSC-derived definitive endoderm (DE) cells are injected into the 
decellularized lung, they would give rise to the desired cell types. However, a huge 
number of these cells are required to regenerate a mouse lung (likely millions) and a pig 
lung (likely billions). Generating this number on 2D culture plates is time-consuming and 
inefficient, as a large number of plates would be required. Stirred flask bioreactors are 
large vessels that can carry large volumes of media. They can be set up so that conditions 
such as oxygen and carbon dioxide levels, the shear stress the cells experience, humidity 
and temperature in the flask resemble the physiological conditions of the human body. 
Many studies have demonstrated the scale-up of 2D cell cultures to 3D suspension 
cultures (Abbasalizadeh et al. 2012, Amit et al., 2011). The largest barrier to overcome is 
the change in environment the cells experience when they are moved from cell culture 
plates, where they normally adhere to the bottom of the plate, to suspension in stirred 
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flask bioreactors. In these studies, 3D suspension culture conditions were made similar to 
2D culture and media changes were done more frequently, to ensure the cells received 
enough nutrients to expand in a large vessel. Additional factors that help cell growth in 
suspension to compensate for the loss of an adherent surface have been used in 
suspension culture studies (Chen et al., Horani et al., 2007). In this study by Chen et al, 
the ROCK (Rho-associated protein kinase) inhibitor was tried to facilitate cell culture 
scale-up. This molecule is known to inhibit apoptosis associated with cell dissociation in 
suspension culture (Watanabe et al., 2007). In addition, the use of serum-free culture 
media eliminates the uncertainty of sourcing associated with animal products (Ozturk and 
Hu, 2006). 3D stem cell suspension cultures are currently maintained in chemically-
defined media which allow for precise identification of media components so that the 
most suitable media can be chosen for the appropriate type of cell culture (Ozturk and 
Hu, 2006). Scale-up of definitive endoderm culture would be highly desirable prior to 
lung recellularization as endodermal progenitor cells (EPs) are closer to mature lung cells 
down the differentiation pathway. Therefore, they might be able to differentiate and 
reconstitute the decellularized lung matrix more easily than iPSCs. The first step prior to 
large-scale cell culture would be to obtain endodermal progenitor cells. IPSC 
differentiation to definitive endoderm has been successful using specific small molecule, 
namely growth factors (Cheng et al., 2012). The main growth factors that drive 
differentiation are Activin and Wnt3a and are added in a precisely timed manner during 
cell culture.  
The extracellular matrix (ECM) plays a crucial role in providing the right environment 
for cell growth, adhesion, proliferation and differentiation. It is not only a physical 
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scaffold for the cells but also induces biochemical and biomechanical signals that 
organize the cells within it (Frantz et al., 2010). This is aided by structural molecules of 
the ECM such as collagen, elastin, laminin and fibronectin which enable the cells to 
adhere in the correct places in a timely manner. A large component of the ECM is 
proteoglycans which can bind growth factors that are secreted by the cells. This 
establishes a growth gradient for the cells during development (Hynes et al. 2009). In 
addition, the ECM itself contains molecules that induce vessel formation, cell migration 
or attachment (Hynes et al., 2009). The ECM is organ and tissue-specific so it is a very 
heterogenous structure (Frantz et al. 2010). The bronchi, for example, have an ECM with 
a very different composition and structure compared to the ECM of the distal part of the 
lung that contains the alveoli. The decellularized lung matrix could provide the correct 
3D structure and molecular cues to direct development of the injected iPSCs or iPSC-
derived DE. Cells injected into synthetic 3D matrices such as poly(lactide) acid (PLA), 
poly (glycolide) acid (PGA) and polyethylene glycol adhere well and interact with the 
synthetic substrate (Villa-Diaz et al., 2013). 3D matrices have the advantage that they 
resemble the physiological state of the living organism compared to 2D cultures. 
Therefore, observations made in 3D culture or matrices will be more relevant as the cells 
reside in an environment strongly resembling their own. Cell growth and viability can be 
improved with the use of bioreactors especially when a large initial cell population is 
used. 3D culture also can improve cell differentiation to definitive endoderm shown by 
increased expression of DE markers and higher cell viability compared to 2D cultures 
(Hoveizi et al., 2013). Many small molecules govern the fate of stem cells during 
development. Normal mammalian development of the lungs begins by the formation of a 
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bud from the primitive foregut and this finely tuned process gives rise to around 40 
different cell types which derive from the endoderm (Krauss-Etschmann et al., 2013). 
The pulmonary vessels and smooth muscle of the airway arise from the mesoderm. The 
expression of the right signaling molecules at a precise time is essential for normal lung 
development. Disruption of this process leads to abnormal pulmonary phenotypes (Rock 
et al. 2012).  Perhaps one of the most important regulatory molecules during development 
is microRNAs (miRNAs). They can bind complementary mRNA sequences and suppress 
their expression after transcription. This way, they can regulate cell proliferation, 
differentiation and programmed cell death (Ekstrom et al., 2007). It is known that 
miRNAs are contained in small vesicles inside the cell called exosomes and can be 
transported from one cell to another, thereby controlling the fates of different target 
tissues (Storvoogel et al. and Andaloussi et al., 2012). 
Exosomes originate from multivesicular bodies (MVBs) in the cell, which are formed by 
the fusion of late endosomes (Stoorvogel et al., 2012). This gives rise to a larger 
compartment surrounded by a lipid membrane containing many vesicles. These MVBs 
can then fuse with the plasma membrane and the vesicles are exocytosed to the 
extracellular environment. The contents of each exosome depend on the cell type they are 
released from and the conditions under which they are released. Exosomes contain small 
RNAs, mainly microRNAs and some rRNAs which are delivered to the extracellular 
environment or target cells if the exosomes fuse with other cell membranes. Many 
biological fluids such as blood, serum, saliva and breast milk contain exosomes, as well 
as cells. Exosomes have been implicated to work as vehicles for miRNA and mRNA 
delivery from one cell to another (Stoorvogel et al., 2012). The mRNA is then translated 
5 
 
to protein in the target cell, which can affect cell function (Valadi et al., 2007). Since the 
miRNAs in exosomes can vary depending on the tissue in which they reside in, the 
presence of these miRNAs have been used for tissue identification. (Liang et al., 2007). 
The miRNAs in the exosomes of neurodegenerate brain tissue differ from normal tissue. 
Exosomes are synthesized in a distinct manner in the cell, involving the plasma 
membrane, trans-Golgi network and lysosomes. The inward budding of these 
compartments relative to the cytosol form MVBs containing the vesicles. It was found 
that proteins such as amyloid precursor protein and prions are associated with exosomes 
and are transported from one cell type to another by exploiting this pathway. There has 
been growing evidence for the exploitation of this pathway in Parkinson’s disease 
progression. The misfolded α-synuclein protein is thought to be transmitted from neuron 
to neuron in exosomes, thereby spreading the misfolded protein to healthy cells. This 
eventually leads to apoptosis of dopaminergic neuronal cells and ultimately disease 
progression towards reduction of the substantia nigra part of the brain (Russo et al. 2012). 
Initial studies of exosomes have shown they have a role in the immune system, for 
example, in dendritic cells (DCs) (Stoorvogel et al., 2012). Depending on the activation 
status of the host dendritic cell, the miRNAs in immature DCs can differ greatly from the 
miRNAs in mature, activated DCs indicating a miRNA signature for these exosomes.  
Studies on multiple myeloma (MM) cells showed that bone marrow mesenchymal 
stromal cell (MSC) exosomes carry unique miRNAs that can be transferred to clonal 
multiple myeloma plasma cells which causes cell proliferation and dissemination, thereby 
enhancing tumor progression. (Roccaro et al., 2013) The same study also demonstrated 
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that exosomes from MM BM (bone marrow)-MSCs carried potentially oncogenic 
proteins that affect MM cell migration and adhesion in the bone marrow 
microenvironment.  
The miRNA can also act as oncogenes or tumor suppressors. Recent studies have shown 
that miR506 can selectively kill late-stage lung cancer cells when ectopically expressed 
(Yin et al., 2014). The molecule is normally used as a marker for lung cancer progression 
since its expression increases toward the end-stage of the disease. When synthetic mimics 
of miR506 were injected into lung cancer cells and normal cells, the former were killed 
whereas the latter were not affected. This is quite similar to the concept of how p53 
becomes oncogenic when it is normally a tumor suppressor. Therefore, when ectopically 
expressed, molecules such as p53 and miR506, will kill cancer tissue and not their normal 
counterparts as their normal functions are to regulate signaling networks in the cell. 
miR506 downregulates NF-κB to decrease cell proliferation and activate p53. Therefore, 
it is postulated that the lung cancer cells have infinite NF-κB signaling and this makes the 
cancer cells more dependent on NF-κB as the cancer progresses. Hence, when miR506 is 
ectopically expressed, late-stage lung cancer cells were the most severely affected. 
Findings like this support the important roles of miRNAs in life-threatening diseases and 
how they can potentially be used as therapeutic molecules for other fatal lung diseases 
such as cystic fibrosis, idiopathic pulmonary fibrosis and chronic obstructive pulmonary 
disease (COPD) (Sessa et al., 2013) 
Similar to the concept of cancer cells versus normal cells, exosomal miRNAs in 
undifferentiated progenitor cells also differ from mature, differentiated cells. These 
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features of exosomes may facilitate the delivery of therapeutic molecules to cancerous 
tissue and help identification of the differentiation stage of a particular cell in tissue 
engineering approaches. In a recent study, miRNA expression profiling showed that 
iPSCs and fibroblasts had distinct miRNA signatures (Porciuncula et al. 2013). Activin A 
is a molecule used for differentiation of iPSCs or ESCs to definitive endoderm. Activin-
induced iPSCs have certain miRNAs, including miR17, upregulated compared to 
untreated iPSCs. This provides evidence that the cells have a miRNA signature unique to 
each stage of cell differentiation. MiR375 is another miRNA known to be highly 
upregulated in definitive endoderm and is highly conserved across species (Hinton et al 
2010). 
Perhaps the most popular tissue engineering approach at present is decellularization of 
the desired organ with various detergents, leaving the extracellular matrix of the organ. It 
is postulated that this decellularized matrix will provide the right niches and 
microenvironment for growth of cells that are injected into the decellularized organ. All 
tissues contain exosomes and their miRNA and protein content vary greatly depending on 
the tissue they originate from so we hypothesized that they may remain in pig and mouse 
lungs after decellularization. Assuming the exosomes are present in decellularized lung, 
their miRNA content can be identified and used to determine whether they induce 
differentiation or self-renewal. This way, the desired exosomes can be used as tools 
during the delivery of the iPSCs, endoderm progenitors, endothelial cells and other lung 
relevant cells to direct the differentiation process to the many various tissues of the lung. 
The exosomes would be co-cultured with the cells on plates before injection into the 
decellularized lung. Furthermore, current decellularization protocols of pig and human 
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lungs involve the use of detergents, de-ionised (DI) water, sodium chloride (NaCl), 
phosphate-buffered saline (PBS) and DNases (Price et al., 2010). This study 
demonstrated the absence of any genomic DNA that may have remained in the pig and 
human lungs after decellularization. A similar study showed this in decellularized pig and 
mouse lungs (Nichols et al, 2013) and in a nonhuman primate model (Bonvillain et al., 
2012). Almost complete recellularization of the pig, mouse and human lungs with 
pulmonary cell types was successfully demonstrated by cell adherence to the acellular 
lung matrices. Cell attachment in the nonhuman primate model was shown with 
mesenchymal stromal cells (Bonvillain et al., 2012). However, it would be useful to 
know if anything remaining in the lung after decellularization could affect or be used as a 
tool in the regeneration process. The detergents are expected to wash out small particles 
such as exosomes because these vesicles have a phospholipid membrane that can bind the 
detergent molecules. However, as the exosomes may get lodged in certain parts of the 
lung such as the distal region, it is possible they may remain after decellularization. More 
importantly, RNases are not used to wash out the lung and exosomes mainly contain 
RNA and protein. This leads to the possibility that exosomes and their contents are 
preserved, even after decellularization. 
 
In order for exosomes to be identified, they have to be analyzed for their RNA and 
protein content. They can be also observed under the electron microscope from a more 
macrobiological perspective. However, this is not enough as they are very small vesicles 
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and not every vesicle can be classified as an exosome. Therefore, their molecular content 
needs to be studied.   
The miRNA relevant to the lung are miR15a, miR29b, miR29c and miR375. miR29b and 
miR29c are mainly expressed in adult pig and mouse lung (Sessa et al., 2013) and 
miR375 expression is highest in definitive endoderm cells (Li et al., 2014). The function 
of miR15a is unknown but is implicated to have a role in cell cycle regulation (Bandi et 
al., 2009). Therefore, it is possible these miRNAs remain in the decellularized mouse and 
pig lungs.  
Overall, the aim of this study was to find a suitable scale-up method to generate sufficient 
numbers of iPSCs and iPSC-derived DE to reconstitute a decellularized lung. The 
specific scale-up method involved 3D culture of iPSCs in a stirred flask bioreactor. In 
addition to this, the existence of exosomes in the decellularized lung was explored to 
identify miRNAs that could possibly be used as tools for directing the development of 
desired cell types in the lung. If found, the exosomes would be co-cultured with iPSCs on 
2D plates to observe any changes in cell phenotype and that way, their potential use in 
the recellularization process would be determined. 
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Materials and Methods 
Bioreactor 
iPS cells re-programmed from human skin fibroblasts (Stem Cell Institute, University of 
Minnesota, Minneapolis, Minnesota) were harvested from 6-well plates that were coated 
with Geltrex (ThermoFisher Scientific Inc, Grand Island, NY) (Figure 1). These cells 
were then placed in a Corning 125ml stirred flask bioreactor at a seeding density of 
750,000 cells per ml in a sterile hood. Rho-associated protein kinase (ROCK) inhibitor 
was added at a 10μM working concentration. Therefore, 1μl of this 10µM solution was 
added as a 1 hour pre-treatment after cell dissocation using 0.5 mM EDTA (Invitrogen 
15575-020 0.5 M EDTA, Invitrogen™, Carlsbad, California) to resuspend the cells and 
pipet them out of the 6-well plates. The cell suspension volume was 5ml so 70ml of 
mTESR™1 medium (Stemcell™Technologies, Vancouver, British Columbia, Canada) 
was added to give a total volume of 75ml (Figure 1). The medium was changed every 2 
days by taking up 35ml medium and replacing it with 35ml of fresh medium. The 
conditions for cell culture were 37˚C, 5%CO2, 4%O2 and pH 7. A pan of water was kept 
in the incubator in order to keep the environment humid, thus preventing the cell cultures 
from drying out. 
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Figure 1: Schematic of bioreactor setup 
Cell count using Trypan Blue Stain 
Trypan Blue passively diffuses through the cell membrane once the cell has undergone 
apoptosis. 10µl of cell suspension was taken from the bioreactor cell culture and mixed 
with 10µl of Trypan Blue stain (Sigma-Aldrich, St. Louis, Missouri). The average 
numbers of total and dead cells were calculated from four counts in a hemocytometer. 
5ml samples of cell suspension were taken every other day and centrifuged for five 
minutes at 1400rpm. The supernatant was taken for metabolite analysis and the cell 
suspension for RNA isolation.  
 
Glucose Assay 
The metabolites analyzed were glucose and lactate. Glucose levels in cell cultures were 
analyzed using a glucose assay kit (Sigma-Aldrich®, St. Louis, Missouri). The process 
essentially involved the oxidation of glucose to gluconic acid and peroxidase by the 
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enzyme glucose oxidase. The peroxidase, which is the enzyme, reacts with o-dianisidine 
reagent, the probe, which is colorless in reduced form. The result is a brown solution of 
o-dianisidine which is unstable. Sulfuric acid is added at the end of the experiment after a 
thirty minute incubation which causes the solution to turn into a range of pink colors. The 
absorbance of these colors at 540nm in a spectrophotometer is proportional to the glucose 
concentration of the sample and this is determined from a set of standards of 0.02, 0.04, 
0.06 and 0.08mg of glucose per ml plotted on a curve. The samples need to be tested at 
several different dilutions to accurately determine the glucose concentration. 1:10, 1:100 
and 1:1000 dilutions were tested for bioreactor samples of days 0, 2 and 4. The day 0 
sample was supernatant from the cells which had been grown on 6-well plates. The 1:10 
dilutions produced absorbance values too high to read off the standard curve and the 
1:1000 dilutions produced absorbances that were too low. The 1:100 dilutions produced 
absorbance values within the range of the standard curve and therefore the glucose assay 
was repeated using only this dilution. 
Lactate Assay 
 The lactate assay was performed using the lactate assay kit (Sigma-Aldrich®, St. Louis, 
Missouri). Firstly, the probe and lactate dehydrogenase enzyme were warmed to room 
temperature before use, protected from light. The lactate dehydrogenase enzyme was 
reconstituted in 220μl of lactate assay buffer. 10μl of the lactate standard provided in the 
kit was combined with 990μl of lactate assay buffer to generate a 1nmol/μl standard 
solution. The concentrations were obtained by plotting absorbances of samples against 
known concentrations of the lactate standard generated. These were added to a 96-well 
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plate. Lactate assay buffer was added to each well bring the volume to 50μl. 2μl each of 
enzyme mix and probe were added to the wells for the standards. Then, 2, 4, 6, 8 and 
10μl of sample were added to the wells and the volume brought up to 50μl with lactate 
assay buffer. The various dilutions of all the samples were taken into account so that 
when the standard curve was generated, the values that fell in the linear part of the curve 
could be selected for data interpretation. The plate was read at 570nm using a 
spectrophotometer (Implen nanophotometer® P330). 
Isolation of RNA 
RNA was isolated using the phenol/chloroform extraction method with Trizol reagent as 
per Invitrogen RNA Isolation with Trizol protocol. The RNA was then purified using the 
Invitrogen RNA purification kit. The RNA concentrations and purities were measured 
using a spectrophotometer (Implen nanophotometer® P330). The spectrophotometer was 
set to RNA measurement. The cuvette and lids were cleaned with 75% ethanol. 1µl of DI 
water was pipetted onto the cuvette and used as a blank. The cuvette was cleaned with 
75% ethanol and then 1µl of sample was pipetted onto the cuvette. The RNA 
concentration and A260/280 readings were recorded. An A260/A280 ratio of at least 2.0 
indicates good RNA purity. 
 
Conversion of RNA to cDNA 
RNA was converted to cDNA using the SuperScript® III first-strand synthesis for qRT-
PCR (Invitrogen™, Carlsbad, California).   Prior to that, RNA samples were normalized 
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to the lowest concentration by dilution with nuclease-free water. Briefly, a master mix 
was prepared with 10μl of RT reaction mix, 2μl of RT enzyme mix, up to 1μg of RNA 
and up to 20μl of diethylpyrocarbonate(DEPC)-treated water. Water pre-treated with 
DEPC is used since this chemical inactivates the RNase enzymes present in the water so 
that there is no RNA degradation. The mixture was incubated at room temperature for 10 
minutes. Then it was placed in the heat block and incubated at 50ºC for 30 minutes. The 
reaction was terminated at 85ºC at 5 minutes and then placed on ice. 1μl of E.Coli 
RNAase H was added to the samples and incubated at 37ºC for 20 minutes. The samples 
were then ready for PCR amplification.  
Amplification of cDNA and agarose gel electrophoresis 
The cDNA was amplified by reverse transcriptase-polymerase chain reaction (RT-PCR) 
using primers for mouse or human β-actin genes, depending on the sample origin. The 
master mix was prepared using 16.25 µl H2O, 2.5 µl 10X salt buffer, 0.1 µl dNTP, 0.15 
µl Taq, 2.5 µl of forward and 2.5 µl reverse primers and 1µl of cDNA sample. These 
values were multiplied by the number of samples required for cDNA amplification. 
The forward and reverse primers for mouse and human cDNA were diluted tenfold. 2µl 
of primer and 18µl of water were put into each of the tubes. Then 2.5 µl of this mixture 
was added to the master mix (which is referred to above).   
The PCR-amplified cDNA was then run on a 1% agarose gel (1% weight/volume in Tris-
Acetate-EDTA buffer) and visualized with ethidium bromide.  
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Lung harvest and tissue homogenization 
Normal and decellularized pig and mouse lungs were used for exosome isolation. Firstly, 
the pig was anesthesized using 200mg of Telazol in 2ml of Xylosine by intramuscular 
injection just above the thigh. Once it was asleep, the ear was searched for veins where 
the syringe could be inserted. 1ml heparin was injected and after a ten minute wait for the 
blood to thin, 4ml beuthanasia was injected to put it down. A stethoscope was used to 
check for any heartbeat. Once this was confirmed, the carcass was taken to the necropsy 
room. The lungs were harvested by making incisions across the abdomen under the ribs 
and on the sides of the chest. A lobe of lung tissue was taken from the lung for exosome 
isolation. The rest was put in the bioreactor for decellularization, using the established 
protocol. (Mortari et al. 2010) 
The lobe harvested from the pig lung was dissected so that sections of distal lung, small 
airway and large airway were obtained until all lung tissue had been utilized. All samples 
were homogenized in 1ml of Trizol using the Teflon homogenizer. The same procedure 
was carried out for the decellularized pig lung. 
Lungs were harvested from mice. The lungs were divided so that each tube had half a 
lung in 1ml Trizol. Decellularized lungs were obtained and also divided in the same way. 
Tissue was homogenized using the Teflon homogenizer.  
Exosome Isolation 
The samples were first enriched for exosomes using the Invitrogen Exosome Isolation kit. 
Briefly, 10ml of each sample was spun at 3000xg for 30 minutes. The supernatant was 
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transferred to a fresh 15ml conical tube and 0.2 parts, in this case 2ml, of exosome 
isolation reagent added. After that, the sample was incubated in the cold room (2-8ºC) for 
30 minutes. Then the sample was divided into 10 eppendorf tubes with 1ml of sample in 
each and centrifuged at 10,000xg for 5 minutes. After the supernatant was aspirated, the 
pellet was resuspended in 100µl of exosome resuspension buffer in each tube. The 
solution was pipetted up and down and the pellet left to dissolve for 10 minutes at room 
temperature. The solutions were then combined back into a 15ml conical tube and kept 
on ice until the RNA isolation step. 
 
Total RNA Isolation from Exosomes 
   RNA was isolated from the samples using the Invitrogen exosome RNA isolation kit 
(Life Technologies™, Carlsbad, California). To begin with, the 2X denaturing solution 
was pre-warmed at 37ºC in a water bath with occasional swirling for 5-10 minutes. The 
resuspended samples were incubated at room temperature for 5-10 minutes prior to RNA 
isolation. Then one volume of 2X denaturing solution was added and the sample 
incubated on ice for 5 minutes. One volume of acid-phenol:chloroform was added. 
Samples were mixed by vortexing for 30-60 seconds and then centrifuged at 10,000xg for 
5 minutes. Two clear layers were formed, with a compact interphase. The upper layer 
was carefully removed, without touching the interphase. All the aqueous phases were 
collected in one tube for each sample type. The elution solution provided in the kit was 
preheated to 95ºC for RNA purification. 1.25 volumes of 100% ethanol was added to the 
aqueous phase and mixed thoroughly. If the samples were more than 700µl they were 
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split into separate tubes as this is the maximum capacity of the filter cartridges, which are 
utilized in the next steps. 700µl of the lysate/ethanol mixture was pipetted onto the filter 
cartridge and centrifuged at 10,000xg for 15 seconds. This step was repeated until the 
whole sample was processed. The flow-through was discarded with each step. The 
sample was washed with 700µl of miRNA Wash Solution 1 and then miRNA Wash 
Solution 2/3. The samples were centrifuged at 10,000xg for 1 minute to dry the filter and 
the filter cartridge placed into a new collection tube. 50µl of the pre-heated elution 
solution was added to the filter cartridge and centrifuged at 10,000xg for 30 seconds. The 
elution was done twice to end up with 100µl of purified RNA. 
RNA quantification 
RNA content was measured using a spectrophotometer (Implen nanophotometer® P330). 
The cuvette was placed inside the device using Lid10 and 1µl elution solution as a blank. 
Then 1µl of each sample was placed onto the glass spot in the middle of the cuvette and 
the lid placed on top. The RNA content was measured. The lid and cuvette were cleaned 
with 75% ethanol between each measurement. An A260/A280 reading of 2.0 would 
indicate high RNA purity, as stated previously. The RNA samples were stored at -80ºC 
for further analyses. 
RNA Analysis 
The isolated RNA samples were then characterized using automated RNA electrophoresis 
(Experion™ Automated Electrophoresis System) and the Experion RNA StdSens 
Analysis kit by Bio-Rad. The RNA samples and ladder aliquot were thawed on ice and 
the reagents allowed to equilibriate to room temperature. The kit comes with two 
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cleaning chips; one for electrode cleaner (EC) and the other for DEPC-treated water 
washes. The machine was washed with both EC and DEPC-treated water. Afterwards, the 
gel solution was prepared and combined with 1µl of stain solution. 9µl of the gel-stain 
solution was loaded onto the chip which was then placed in the priming station. After 
priming was complete, the chip was checked for any trapped air bubbles or incomplete 
priming. About 3µl of ladder and samples were transferred into fresh microcentrifuge 
tubes which were incubated at 70ºC for 2 minutes to denature the RNA strands and then 
kept on ice for 5 minutes. They were spun down and kept on ice until the chip was 
loaded. The chip was then loaded with another 9µl of gel-stain solution in the upper GS 
well followed by 9µl of filtered gel solution in the G well. 5µl of loading buffer was 
pipetted into all the sample wells including the ladder well. 1µl of ladder was pippeted 
into the L well and 1µl of sample into each respective sample well. The chip was placed 
in the Experion vortex station for 1 minute. It was important to make sure the chip was 
run 5 minutes within loading the samples. The chip was placed in the electrophoresis 
station and the Eukaryotic RNA StdSens Assay chosen which detects total eukaryotic 
RNA. The chip was discarded when the run was complete and the electrodes rinsed with 
DEPC-treated water. The images of all spectra, the virtual gel and the RNA quality index 
(RQI) of all samples were recorded. 
The whole RNA analysis was repeated for the decellularized pig and mouse lung samples 
but this time the decellularized samples were done in duplicate to get a total of eight 
samples. 
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Finally, a total RNA sample from normal pig lung was run on the chip to observe the 
typical peaks seen for cellular samples. The RNA was isolated using the Invitrogen 
protocol with Trizol reagent. 
Reverse Transcription of miRNA 
Reverse transcription was performed using six primers of miRNAs that are known to 
have a role in lung development using the Applied Biosystems miRNA reverse 
transcription kit.  
Two of them, miR 17 and snoRNA202 were chosen as positive endogenous controls for 
the qRT-PCR since they are known to be stably expressed in both mouse and pig tissue. 
The other primers tested were miR15a, miR375, miR29b and miR29c (Applied 
Biosystems®, Grand Island, NY). 
Briefly, a master mix was prepared for 26 reactions which would be equivalent to two 
primers plus a reaction to compensate for possible pipetting errors The thermocycler has 
a limited capacity for PCR tubes so the samples were reverse transcribed in pairs. The 
amount of each reagent stated in the protocol was multiplied for 27 reactions, allowing 
extra volume for pipetting errors. Briefly, 112.32μl of nuclease-free water was pipetted 
into a 600μl microcentrifuge tube along with 40.5μl of 10X RT(reverse transcription) 
buffer, 27μl of Multiscribe™ RT enzyme, 5.13μl of RNase inhibitor and 4.05μl of dNTP 
mix. The resulting master mix was centrifuged for ten seconds to bring all the solution to 
the bottom of the tube. The first two reverse transcription reactions were run using 
primers sno202 and miR17 which would ultimately be used as the endogenous controls in 
the qRT-PCR reaction. 7μl of master mix was pipetted into each PCR tube followed by 
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5μl of RNA sample into the respective tubes. Afterwards, 3μl of the 5X RT primers were 
added to the mixture and all tubes were centrifuged for about ten seconds to bring all the 
solution to the bottom. The thermal cycler was run with the following conditions: HOLD 
at 16ºC for 30 minutes, HOLD at 42ºC for 30 minutes and finally HOLD at 85ºC for 5 
minutes. The machine then holds the samples at 4ºC until collection. This was done for 
miR15a and miR29b in the second round of reverse transcription and miR29c and 
miR375 in the third round. The samples were stored at -20ºC until further analysis.  
Probe Known Functions 
sno202 Housekeeping gene 
miR17 Housekeeping gene 
miR15a Cell cycle regulation 
miR29b Regulation of ECM deposition and 
remodeling 
miR29c Unknown 
miR375 Differentiation to definitive 
endoderm/development of endoderm 
Table 1: Probes used for real-time PCR analysis of exosome miRNA and their 
known functions. 
Measurement of copyDNA(cDNA) content 
The cDNA content of the samples were measured using the spectrophotometer (Implen 
nanophotometer® P330). The program was set to nucleic acids then single-stranded DNA 
and the concentration, A260/280 and A260/230 values were recorded. An A260/280 ratio 
of at least 1.8 and an A260/230 ratio between 2.0 and 2.2 are indicators of good quality 
DNA. Phenolic contaminants such as Trizol will absorb at both 230nm and 280nm and 
proteins absorb highly at 280nm. Other contaminants such as EDTA and carbohydrates 
absorb highly at 230nm so if the sample has a high absorbance at 260nm compared to 
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280nm and 230nm then a good ratio will appear. Nuclease-free water was used as a 
blank. 1µl of each sample were used to measure DNA concentration. 
Real-time RT-PCR 
Firstly, the cDNA from the reverse transcription was tested to see if it required any 
dilution. The qRT-PCR instrument is very sensitive and can detect amounts of cDNA as 
low as the picogram level. Therefore, 1-100ng cDNA is the ideal range that should be 
aimed for. According to the cDNA concentrations generated from reverse transcription, 
the ideal amount of total cDNA would be obtained if 1.33μl of RT product is put in a 
20μl PCR reaction. Therefore, the experiment was conducted without any cDNA dilution. 
Prior to commencing the experiment, a template was prepared for the 96-well plate on 
Applied Biosystems software for the PCR run. 
 10μl of Taqman Universal Master Mix and 7.67μl of nuclease-free water is required for 
each well. Four wells were used as ‘no template controls’ and contained 10μl of master 
mix and 10μl of nuclease-free water. 1μl of each Taqman probe and 1.33μl of each 
cDNA sample were added to the designated sample wells. After centrifuging the plate at 
1,000xg for one minute, to ensure all of the samples were brought from the sides of the 
wells to the bottom, it was then placed in the PCR instrument and run using the following 
conditions: 50ºC for 2 minutes, 95ºC for 10 minutes, 95ºC for 15 seconds (40 cycles) and 
60ºC for 1 minute. The data was analyzed using ABI software and all mouse samples 
were normalized to non-decellularized mouse lung and all pig samples normalized to 
non-decellularized distal pig lung. 
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Bradford Assay 
Exosomes also contain a significant amount of protein. The Bradford assay exploits a 
blue dye in the Bradford reagent, called brilliant blue G which binds to proteins and 
changes the absorption maximum of the dye. Bovine serum albumin (BSA) is used as a 
standard reference protein in these assays. A serial dilution of the BSA was made to plot 
a standard curve. 1:5 dilutions of the exosome samples were used and the absorbance was 
measured at 595nm.  
iPSC culture to definitive endoderm 
Isolation of exosomes for cell culture 
Exosomes were isolated from decellularized pig lung by dissection of distal parts of the 
lung followed by homogenization of the tissue as previously described. Exosomes were 
isolated using an exosome isolation kit for serum (Invitrogen™, Carlsbad, California). 
The resulting sample was filtered using a 0.22μm from Millipore to avoid contamination 
of the cell culture. The approximate amount of exosomes was measured by quantifying 
the amount of protein in the sample using the Bradford assay. 
Cell Culture 
Passage 14 human iPSCs (courtesy of Dr. Nobuaki Kikyo’s laboratory, Stem Cell 
Institute, University of Minnesota, Minneapolis, MN) that were grown on Geltrex 
(Invitrogen™, Carlsbad, California) were used for differentiation to definitive endoderm. 
A 12-well plate was prepared with the first group designated to the differentiation of 
iPSCs to definitive endoderm with exosomes added. The second group was for iPSC 
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differentiation to definitive endoderm without exosomes and the last group was used as a 
negative control, namely iPSCs cultured in essential 8 medium for their maintenance 
(Table 2). Samples were taken at day 0 and day 6 from each quadruplicate for RNA 
analysis and gene expression. 
Group Differentiation Factor Exosomes Anticipated Result 
1 Basal differentiation 
media, Act, Wnt, β-
mercaptoethanol, FBS 
+ Change in cell 
phenotype different 
from group 2 
2 Act, Wnt, β-
mercaptoethanol, FBS 
- Change in cell 
phenotype 
3 None - No change, remain 
as undifferentiated 
iPSCs 
Table 2: Experiment setup for iPSC culture to definitive endoderm 
At day 2.5, pictures of each well were taken using bright field microscopy (Leica 
Microsystems, DMI 3000) before the media change. All wells were subjected to a half 
media change. The same procedure was carried out on day 5. 
On the last day of cell culture (day 6), pictures of each well were taken using brightfield 
microscopy (Leica Microsystems, DMI 3000). Then 1ml of Trizol reagent was put into 
the wells and pipetted up and down to make sure the cells mixed with the Trizol reagent. 
Finally, this mixture was pooled for each row of wells into 15ml conical tubes for RNA 
and gene expression analysis. 
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RNA isolation and purification 
RNA was isolated in the same way as it was done in the bioreactor experiment using 
Trizol reagent (Invitrogen™, Carlsbad, California). RNA purification was also done as 
previously using the RNA mini kit (Invitrogen™, Carlsbad, California). 
Automated gel electrophoresis 
This was done the same way as for the normal and decellularized lung miRNA samples. 
Cell culture samples were done in triplicate in the 12-well chip.  
Reverse Transcription 
RNA was converted to cDNA using the SuperScript® III first-strand synthesis for qRT-
PCR (Invitrogen™, Carlsbad, California), same as the bioreactor samples. 
qRT-PCR of cell culture samples  
This part was carried out in the same way as qRT-PCR was done for the samples from 
the bioreactor experiment. The probes used included markers for undifferentiated iPSCs, 
definitive endoderm and more mature lung cell markers as shown in Table 3 below. 
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Probe Name Known Function 
Oct 2 Maintains pluripotency in iPSCs 
Sox 4 Maintains pluripotency in iPSCs 
Nanog Maintains pluripotency in iPSCs 
Vimentin Intermediate-filament protein. Marker of mesenchymally-derived 
cells 
Pax8 Required for endoderm formation 
Pdx1 Definitive endoderm marker 
FoxA2 Definitive endoderm marker 
Sox17 Definitive endoderm marker 
SPC Surfactant protein C, found in type II pneumocytes 
AQP5 Aquaporin 5 is found in type I pneumocytes 
CC10 Club cell marker found in small airway epithelia 
FoxJ1 Required for cilia formation in airway and alveolar epithelial cells 
TTF1 Role in lung morphogenesis and regulation of surfactant proteins, 
found in type II pneumocytes and non-ciliated bronchiolar 
epithelial cells 
Sox9 Lung morphogenesis, distal progenitor marker  
p63 Transcription factor involved in lung development 
CK5 Keratin protein expressed in epithelial tissue 
Table 3: Markers used in real-time PCR of samples from iPSC culture to definitive 
endoderm 
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RESULTS 
Cell Count 
 
Figure 2: Number of cells and how they changed over 8 days of culture in stirred 
flask bioreactor. Error was calculated using standard error (Cumming et al, 2007) 
The cell count at day 0 was 52.3 million cells. This value rapidly decreased to 20 million 
upon commencement of culture in stirred flask bioreactor. This is expected in the 
transition from 2D to 3D culture as the latter has low oxygen levels that the cells have to 
adjust to. Consequently, cell numbers increased back to 72 million on day 4, indicating 
adaptation to 3D culture conditions. Usually, cell numbers would continue to increase 
until cell passage is required. On the contrary, cell numbers drop rapidly to 20 million on 
day 6 and 5.25 million on day 8. This is an indicator of unsuitable 3D culture conditions. 
The iPSCs need extra support in the form of a matrix or additional growth factors. 
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RNA isolation and agarose gel electrophoresis  
No detectable RNA was found by the RNA isolation method in any of the samples from 
the stirred flask bioreactor culture but agarose gel electrophoresis was still carried out to 
check if GAPDH was present and if any RNA was isolated. No RNA appeared in the lane 
for GAPDH but only the ladder was clearly visible (Figure 3), indicating that the gel was 
run correctly but there must have been a flaw in the amplification of GAPDH or that the 
cells were dead. Alternatively, the RNA isolation was not done properly and was lost in 
processing. 
                                    1        2         3        4         5        6         7          8        9         10 
  
Figure 3: Image of agarose gel faintly showing the ladder in lanes 1 and 5 
Lactate Assay 
The lactate assay gave a linear standard curve, as expected. There are a couple of outliers 
but they were not far from the standard curve line. As the lactate concentration increased, 
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the absorbance of the standards at OD570 increased by the same amount which can also 
be seen in Table 4. This demonstrates the linearity of relationship between lactate 
concentration and absorbance at 570nm as shown below in Figure 4 (upper figure). 
 
 
Figure 4A: Set of standard concentrations for lactate assay. 4B: Lactate levels in 3D cell culture over the course 
of 6 days. Error bars for both graphs are calculated using standard error with n=3 (Cumming et al, 2007) 
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 An equation was generated from the standard curve and used to determine the lactate 
concentration in the samples tested, which were from days 1, 2, 4 and 6 of the stirred 
suspension culture. Table 4 shows the calculated lactate concentrations for all the 
different absorbance values generated at 570nm for different sample solution strengths. 
The first column shows a 25-fold dilution and the second column a 12.5 dilution and so 
on. The 6.25-fold dilution was picked for analysis as these values all fell in the linear part 
of the curve. A graph of lactate concentration versus day was plotted to better visualize 
the changes in lactate concentration from days 1-6 (Figure 4, lower figure). According to 
the graph, lactate concentrations were very high on the first day followed by a big drop 
on the second day and then a slower, more gradual decrease after day 2 until day 6. This 
indicates that the cells were producing lactate on the first day and the dramatic decrease 
points to the sudden cell death observed. Any remaining cells then slowly diminished 
after day 2. 
 
Table 4: Calculated lactate concentrations of bioreactor samples at days 1, 2, 4 and 6 with 
various dilutions shown in row 1. 
Glucose Assay 
The curve generated from the standard set of concentrations was completely linear 
(Figure 5). The absorbance values at 540nm were directly proportional to the glucose 
concentration in the standard solution.  
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Figure 5: Set of standards for glucose assay. Error bars using standard error with 
n=3 (Cumming et al, 2007) 
As in the lactate assay, the equation of the standard curve was used to determine the 
glucose concentrations of bioreactor samples. The absorbance values were substituted as 
the y-values in the equation to find the x-values. The results were then multiplied by 100 
as the dilution was 1:100 (Table 5).  
Day Absorbance value 
at 540nm 
Glucose Concentration 
(mg/ml)  
0 0.096 0.29 
2 0.587 3.52 
4 0.261 1.38 
Table 5: Determined glucose concentrations for bioreactor  
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RNA isolation from exosomes 
Exosomes were isolated successfully from normal and decellularized pig and mouse lung 
tissue followed by RNA isolation. The exosome isolation was determined successful by 
checking for the presence of a small gel-like pellet during the last 10,000xg 
centrifugation step of the exosome isolation protocol. In some cases, it was not be visible 
however some of the samples showed evidence of this pellet. Nevertheless, this is not 
enough to confidently say there are exosomes in the samples. Further analysis is required 
by identifying the RNA and protein content of these vesicles.  
RNA concentration measurement 
The RNA concentrations were measured using the Implen nanophotometer® P330 (Table 
4). The large airway of the normal pig lungs have the highest RNA concentration 
followed by pig distal lung, mouse lung and finally the pig small airway controls. In both 
of the decellularized lung samples 1 and 2, pig distal lung had the highest RNA 
concentration followed by small airway, mouse lung and finally, large airway. It is not a 
surprise that the normal lung samples had much higher RNA concentrations than their 
decellularized counterparts. It may be possible that the large airway sample obtained 
happened to have the largest amount of RNA due to the amount of tissue extracted. Since 
the normal lung samples were only processed once, it would not be possible to confirm 
this until the experiment is repeated for these normal lung samples.  
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There were differences in RNA content between the first and second sets of lungs with 
the first having higher concentrations of RNA for mouse, pig alveolar and large airway. 
The pig distal lung among the first batch of decellularized lungs had an unusually high 
concentration of RNA which could be partially explained by the low RNA purity. If an 
RNA sample is not pure or clean, the concentration value will be abnormally high due to 
the absorption of impurities such as proteins. Proteins absorb at the same wavelength as 
RNA so the concentration value can be misleading however the A260/280 ratio is helpful 
in these cases.  The results for the second set of lungs were reproducible in that they had 
similar RNA concentrations to the first batch. The A260/A280 ratios represent RNA 
purity in that A260 means absorbance at 260nm and A280 means absorbance at 280nm 
wavelengths. Nucleic acids typically absorb at 260nm and contaminants such as Trizol 
used in the RNA isolation processes absorb at 280nm. Therefore, an absorption spectrum 
would have a peak at 260nm that is twice as high as the peak at 280nm, giving a ratio of 
2. The ratios that are 2.0 or higher would qualify as ultra pure RNA and ratios of 1.8 
would be acceptable quality. However, ratios below 1.8 would be classified as poor 
quality RNA. Referring to Table 4, all the normal lung samples have ultra pure RNA. The 
first batch of decellularized lung samples did not yield high quality RNA but the second 
batch had ultra-pure RNA for mouse lung, small airway, large airway and distal pig lung 
had acceptable RNA purity. The overall RNA quality was much better for the second 
batch of decellularized lungs. 
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Automated RNA electrophoresis 
After determining the purity of the RNA, the next step was to investigate what kind of 
RNA was isolated. As exosomes are highly enriched for miRNA, the presence of high 
amounts of these short sequence nucleotides would indicate that, indeed what was 
isolated were exosomes. The same sets of lungs were used as for the RNA concentration 
measurements. Figure 6 shows the results for the ladder appeared as expected, with its 9 
characteristic peaks of certain shape and height. The RNA peaks in this experimental 
method are specific to the type of RNA present. MicroRNA typically appears at the early 
part of the experiment (between 25 and 35 seconds) so the peaks on the left-hand side of 
the graph were broader compared to the earlier peaks. The height of the peak represents 
the amount of miRNA present. 
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Sample RNA concentration 
(µg/ml) 
A260/A280 
Normal mouse lung 433 2.146 
Decellularized mouse lung (1st batch) 8.748 1.600 
Decellularized mouse lung (2nd batch) 8.35 2.300 
Normal distal pig lung 413 2.149 
Decellularized distal pig lung (1st batch) 117 1.500 
Decellularized distal pig lung (2nd 
batch) 
11.5 1.812 
Normal small airway 102 2.246 
Decellularized small airway (1st batch) 22.7 1.500 
Decellularized small airway (2nd batch) 9.940 2.273 
Normal large airway 473 2.138 
Decellularized large airway (1st batch) 7.157 1.200 
Decellularized large airway (2nd batch) 7.157 2.000 
Table 6: RNA concentrations and purity measures for normal and decellularized 
mouse and pig lungs. 
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Figure 6: RNA ladder for automated gel electrophoresis 
The automated RNA electrophoresis method uses a fluorescent dye to measure the 
amount of RNA in a particular sample. The samples are pipetted into a tiny chip with 
microfluidic channels at the bottom. When the electrodes in the device come in contact 
with the fluid in the chip, a current is generated, which initiates the process of small 
molecule migration similar to agarose gel electrophoresis or SDS-PAGE. The smaller the 
molecule, the faster it will migrate. Therefore, the first RNA molecules to appear on the 
graph will be the small RNAs such as microRNAs and long non-coding RNAs. This will 
be followed by messenger RNA and then the respective ribosomal RNAs, depending on 
the species being tested. The heights of the peaks will vary depending on the fluorescence 
intensity, which directly represents the amount of that particular type of RNA. The first 
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small peak in the graph represents a reference peak which the device uses as a base value 
when generating the other peaks. 
The peaks have a definite shape, height and size and the ladder provided in the kit is a set 
of RNA molecules of known molecular weight. They are known to produce defined 
peaks as above. The first six peaks are narrow and sharp while the last two are smaller 
and broader. According to the data provided by BioRad™, the peaks in Figure 6 appeared 
in the expected manner. This ladder can be used to estimate the molecular weights of 
unknown samples of RNA. 
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Figure 7: Automated RNA electrophoresis spectra for normal lung samples. Arrows 
indicate the peaks for miRNAs. The area under these peaks from 25 to 35 seconds is 
the time for miRNA appearance. 
 
Figure 7A: Automated RNA electrophoresis spectrum for normal mouse lung 
 
Figure 7B: Automated RNA electrophoresis spectrum for normal pig distal lung 
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Figure 7C: Automated RNA electrophoresis spectrum for normal pig small airway 
 
Figure 7D: Automated RNA electrophoresis spectrum for normal pig large airway 
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According to Figure 7, there is a high amount of small, short sequence RNAs for all 
normal lung samples. The next smaller but broader hump shows the typical peak for 
mRNAs, which is a common component of normal lungs (2
nd
 arrow in Figures 7A, B and 
C).  The large amount of exosomes found in all normal lung samples are due to the 
presence of cells which contain MVBs. These are the main source of exosomes therefore 
a high level of fluorescence is observed for all normal lung samples. The wider peaks 
indicate the presence of more RNA sequences of different lengths. The pairs of dots 
further to the right represent the 18S and 28S ribosomal RNA peaks. Cellular samples 
would have tall, sharp peaks at both these points like in Figure 7E. Since exosomes were 
isolated before automated gel electrophoresis, these sharp peaks are absent in Figures 7A-
D. This indicates that the sample did not contain 18S or 28S rRNA. In contrast, Figure 7E 
shows that the 18S and 28S peaks are clear and sharp when cellular RNA is run on the 
chip.  
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Figure 7E: Automated electrophoresis spectrum for normal pig lung. Arrows indicate the 
18S on the left and 28S peak on the right. 
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Figure 8: Virtual gel image of RNA from normal lung samples generated by the 
Experion automated electrophoresis instrument. From left to right: L-Ladder, 1-
mouse lung, 2-pig distal, 3-pig small airway, 4-pig large airway 
The bands in lanes 1-4 (Figure 8) are very clear-cut and thick which reflects the tall peaks 
seen in all normal lung samples (Figures 7A-D). This indicates the presence of significant 
amounts of miRNA in all normal lung samples.  
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Figure 9: Automated RNA electrophoresis for 1st set of decellularized pig and 
mouse lungs. A: mouse, B: pig alveolar, C: pig small airway, D: pig large airway 
 
Figures 9A and 9B 
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Figures 9C and 9D 
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The decellularized mouse lung did not give rise to any significant peak (Figure 9A) 
however the pig lungs did, with the alveolar or distal region having the largest peak 
(Figure 9B). The large airway and the small airway had smaller peaks (Figures 9C and 
D). This does not correlate with the RNA concentrations obtained during the RNA 
isolation step (Table 5). The reference peaks appear in the expected places which are 20-
25 seconds and 8-10 fluorescence units. The 18S and 28S ribosomal RNA peaks do not 
appear which demonstrates successful exosome isolation. There is also no mRNA hump 
straight after the small RNA region which also strongly indicates that the RNA peaks 
belong exclusively to exosomes.  
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Figure 10: Automated RNA electrophoresis results for 2nd set of decellularized pig 
and mouse lungs. A: mouse, B: pig alveolar, C: pig small airway and D: pig large 
airway 
 
 
Figure 10A and Figure 10B 
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The second batch of decellularized mouse lung also showed no significant level of 
fluorescence (Figure 10A). The pig alveolar sample had the highest fluorescence peak 
(Figure 10B). This time, however, the large and small airway samples had approximately 
the same amount of fluorescence (Figures 10C and 10D). The overall heights of the peaks 
were also much lower than the first set of decellularized lungs. This may explain the 
unusually high RNA concentrations for the first set of decellularized lungs, giving rise to 
large peaks in the electrophoresis charts. Their A260/A280 ratios were low which 
indicates contamination so the RNA peaks in Figure 9 were higher than the actual amount 
of RNA. This may be the reason for the lower peaks in Figure 10, as the RNA content 
was very pure and produced a more realistic amount of the RNA quantity. The reference 
peaks appeared at the right time, between 20 and 25 seconds on the chart and at the right 
fluorescence level between 7 and 8 units.  
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Figures 10C and 10D 
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Figure 11: Automated RNA electrophoresis results for DEPC-treated water 
 
 
Figures 11A and 11B 
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Figures 11C and 11D 
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The wells above (Figure 11) contained DEPC-treated water which was to ensure that the 
loading buffer that was added to the other wells with the RNA samples was not 
contaminated. Assuming the loading buffer was not contaminated, no RNA peaks should 
be seen on these charts and this holds true for all four wells. Therefore, the fluorescence 
peaks that appear in the normal and decellularized lung samples will only be derived 
from the sample itself and not the loading buffer, which allows accurate quantification of 
RNA content.  
 
Figure 12: Virtual gel image of RNA from decellularized lungs samples generated 
by the Experion automated electrophoresis instrument. From left to right: 1-mouse 
lung 1, 2-pig distal 1, 3-pig small airway 1, 4-pig large airway 1, 5-mouse lung 2, 6-
pig distal 2, 7-pig small airway 2, 8-pig large airway 2, 9-12: DEPC-treated water 
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The virtual gel image created by the instrument (Figure 12) also showed evidence of 
miRNA presence by the faint bands of about 50-200 nucleotides present in lanes 2 (pig 
distal), 4 (large airway) and 6 (pig distal of second set). The lower the peak the more 
smeared the band will look in the image. The DEPC-treated water appeared blank which 
indicated complete absence of RNA molecules as previously evident from the spectra. 
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Sample RNA quality index  
(2 decimal places) 
Normal mouse lung 2.88 
Decellularized mouse lung (1
st
 batch) 0.72 
Decellularized mouse lung (2
nd
 batch) 0.00 
Normal distal pig lung 1.88 
Decellularized distal pig lung (1
st
 batch) 0.42 
Decellularized distal pig lung (2
nd
 batch) 0.42 
Normal pig small airway 0.00 
Decellularized pig small airway (1
st
 batch) 0.24 
Decellularized pig small airway (2
nd
 batch) 1.42 
Normal pig large airway  0.00 
Decellularized pig large airway (1
st
 batch) 4.06 
Decellularized pig large airway (2
nd
 batch) 3.69 
DEPC-treated water (well 9) 0.47 
DEPC-treated water (well 10) 0.21 
DEPC-treated water (well 11) 0.65 
DEPC-treated water (well 12) 2.24 
Table 7: RNA quality index (RQI) of normal lung samples from first electrophoresis 
run and decellularized lung samples and DEPC-treated water wells from second 
electrophoresis run. 
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The RNA quality index (RQI) is a value that represents the overall quality of an RNA 
sample. It uses an algorithm based on many features of the sample spectrum such as the 
height of the peak for 18S rRNA and the ratio of the rRNA peaks to the total area of the 
electropherogram. It uses a set of standardized degraded RNA for comparison with the 
tested samples and uses the algorithm to generate a value between 1(low quality) and 10 
(high quality) RNA. RQI numbers were surprisingly low (Table 7) as the previous 
measurements of RNA concentration and A260/A280 ratios were of acceptable purity for 
the normal lung and second batch of decellularized lungs. A couple of anomalies were 
normal mouse lung, and decellularized pig large airway from the 1
st
 and 2
nd
 batches. 
These were of better RNA quality. It is possible that the RNA degraded during the 
preparation of the chip for automated gel electrophoresis. The DEPC-treated water also 
contained ribosomal RNA which is a sign of minimal contamination. In addition, this 
algorithm for RQI is generally used for cellular RNA samples, as the algorithm is based 
on the 18S and 28S values. Therefore, we cannot rely on the RQI values since the RNA 
samples here were isolated from exosomes. 
qRT-PCR 
The data showed that all the miRNAs were expressed significantly more in normal mouse 
lung compared to the decellullarized mouse lungs. The same applied to pig distal lungs. 
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Figure 13: Expression levels of microRNAs in normal mouse lung versus 
decellularized mouse lung. The average Ct percentage variance for each sample 
done in quadruplicate tested for each gene was less than 5% (Cumming et al., 2007) 
All the results were normalized to pig distal lungs as these had the highest amount of 
RNA. The software sets the calibrator as ‘1’ which is the maximum relative quantity 
value. Therefore, assigning the relative quantity as ‘1’ for the sample that had the highest 
amount of RNA would provide the opportunity to observe the relative expression of all 
the other samples, which had lower levels of RNA. Figure 13 shows that normal mouse 
lung mostly expressed miR15a and miR375, with some miR29c and minimal amounts of 
miR29b. The decellularized mouse lung does not have any microRNA expression, 
suggesting the absence of exosomes. Profiling for miR375 on all decellularized samples 
was done separately. Then, the data from this plate was added to the bar charts and 
displayed along with the other miRNA probes.  
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Figure 14: Expression levels of microRNAs in normal versus decellularized distal 
pig lung. The average Ct percentage variance for each sample done in quadruplicate 
tested for each gene was less than 5% (Cumming et al., 2007) 
As expected, the normal pig distal lung region has much higher miRNA expression than 
its decellularized counterpart (Figure 14). All three miRNAs miR15a, miR29b and 
miR29c were still present in decellularized pig distal lung, the highest being miR15a 
followed by almost equal amounts of miR29b and miR29c. 
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Figure 15: Expression levels of microRNAs in normal pig small airway versus 
decellularized pig small airway. The average Ct percentage variance for each sample 
done in quadruplicate tested for each gene was less than 5% (Cumming et al., 2007) 
The normal small airway samples overall had less miRNA expression than pig distal 
lung. Mir29c had the higher expression while the other three had about the same level of 
expression at a lower relative quantity compared to miR29c. The decellularized small 
airways had an undetectable amount of RNA (Figure 15). Importantly, all decellularized 
pig distal lungs had as much as three-fold higher miRNA expression compared to normal 
small airways. This indicates the many small niches distal lung has which may have 
trapped the miRNAs despite the decellularization whereas the small airways probably did 
not due to their simpler, tubular geometry. 
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Figure 16: Expression levels of microRNAs in normal pig large airway versus 
decellularized pig large airway. All samples are normalized to distal pig lung (non-
decellularized). The average Ct percentage variance for each sample done in 
quadruplicate tested for each gene was less than 5% (Cumming et al., 2007) 
Normal large airway samples had very low amounts of all miRNAs (Figure 16), even less 
than the normal small airway samples (Figure 15). This may reflect the effect of the 
decellularization process on cavities such as the large airway which possibly does not 
contain a lot of the miRNA probes tested for. As the large airways contain the most 
cartilage and are relatively distant from the actual lung tissue, they may not contain the 
miRNAs typically expressed in the distal lung.  
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Figure 17: Expression levels of microRNAs in normal mouse lung versus decellularized 
mouse lung of the second batch. The average Ct percentage variance for each sample 
done in quadruplicate tested for each gene was less than 5% (Cumming et al., 2007) 
 
Figure 18: Expression levels of normal pig lung versus decellularized pig lung from the 2nd 
batch. The average Ct percentage variance for each sample done in quadruplicate 
tested for each gene was less than 5% (Cumming et al., 2007) 
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Surprisingly, decellularized mouse lungs from the second batch had higher relative 
expression of all probes compared to normal mouse lungs (Figure 17). This contradicts 
the data obtained for the RNA concentrations of these samples (Table 5) and perhaps 
indicates technical errors during the conversion to cDNA or real-time PCR. Overall, 
decellularized pig large airway had the highest relative expression for miR15a, miR29b 
and miR375 (Figure 18) whereas decellularized distal pig lung was the most highly 
expressed in the first batch of decellularized samples (Figure 14). The only expression 
was mir29c, which was most highly expressed in decellularized distal pig lung. There 
was no detectable expression of miR29b in decellularized distal pig lung and 
decellularized small airway. The heterogeneity in this real-time PCR data may be due to 
the batches coming from two separate lung tissue sources. 
  
Bradford Assay  
The concentrations of protein in the lung samples were calculated using the BSA 
standard curve. The overall protein concentrations in the normal lung samples were much 
higher than their decellularized counterparts (Table 8). Among the normal lung samples, 
mouse lung had the largest amount followed by pig distal, large airway and then small 
airway. This is the same trend seen in the RNA concentration measurements where the 
small airway had less RNA than the large airway in normal lungs. However, when it 
came to decellularized lungs, pig small airway samples had the largest amount of protein 
with a similar amount in large airway followed by pig distal lung and then mouse lung. 
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This is in contrast to the RNA concentrations as the decellularized distal pig lung was the 
highest in that case (Table 6). It can be concluded from the data that a specific RNA 
concentration in a sample does not have to correlate with the protein concentration from 
that same sample however for the most part, the RNA and protein concentrations of both 
normal and decellularized samples seem to have a significant positive correlation (Figure 
19). 
Sample OD595 Calculated protein 
concentration (mg/ml) 
Mouse lung 1.445 2.331 
Distal pig lung 1.055 1.476 
Pig small airway 0.756 0.821 
Pig large airway 0.854 1.036 
Decellularized mouse 
lung  
0.527 0.319 
Decellularized pig 
distal lung 
0.592 0.461 
Decellularized pig 
small airway 
0.634 0.553 
Decellularized pig large 
airway 
0.627 0.539 
 
Table 8: Calculated protein concentrations in normal and first set of decellularized 
lungs 
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Figure 19: Comparison of observed RNA and protein concentration in exosomes 
from all samples. 
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Quantification of exosomes for cell culture 
Using the BSA standard curve, the protein concentration of the decellularized distal pig 
lung exosome sample was calculated using sample without dilution, 1:10 and 1:100 
dilutions as shown below in Table 9. However, the OD reading did not go down with 
dilution indicating a very high amount of protein in the sample. The Bradford assay tends 
to show high variability, especially in samples with higher protein concentrations (Lu et 
al., 2010). Nevertheless, the estimated value was significantly high to be used in cell 
culture, based on previous exosome delivery research (Wahlgreen et al., 2012). In this 
study by Wahlgreen et al., plasma exosomes were delivered to monocytes and 
lymphocytes silence a gene responsible for the inflammatory response. The exosome 
concentration they used was in the range 0.25-1µg/µl and their dose-response 
experiments showed that about 500µg of exosomes were necessary to completely silence 
the gene. Therefore, I postulated that this figure would be my threshold exosome 
concentration to go by and since I observed 0.772µg/µl in my sample without dilution, I 
went by this concentration. My sample volume was 1.5ml which meant that it contained 
the required amount of exosomes. 
Sample OD595 Protein concentration 
(mg/ml) 
No dilution 0.760 0.772 
1:10 0.789 8.419 
1:100 0.767 78.9 
        Table 9: Estimated protein concentrations of exosomes from decellularized pig 
distal lung 
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iPSC culture to definitive endoderm 
 
Figure 20: Brightfield images of iPSCs at day 0 of differentiation to definitive 
endoderm. A-iPSCs with Act, Wnt and exosomes from decellularized distal pig lung, 
B-iPSCs with Act and Wnt and C-just iPSCs in E8 medium. The scale bar is 200μm. 
At day 0 of differentiation, iPSCs from all wells appeared similar in morphology and 
size, and were quite dispersed across the plate. Individual colonies could be easily 
visualized. The exosomes from decellularized distal pig lung were added on to the first 
two groups of iPSCs on day 2.5. The appearances of the cells at this point were not much 
different to the ones at day 0 of differentiation. Even the wells to which only Activin and 
iPSCs in E8 
media 
iPSCs with Act+Wnt iPSCs with Act+Wnt+exosomes 
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Wnt were added did not show any significant difference in cell morphology and 
distribution. By day 6, the wells with the exosomes added exhibited different morphology 
compared to the wells to which only activin and wnt were added (Figure 21) as 
demonstrated by the clumps that the cells formed (Figure 21A). The wells to which 
nothing was added preserved the typical round morphology of iPSCs, as expected (Figure 
21C). 
  
 
 
 
 
 
 
 
Figure 21: Cells at day 6 of differentiation to definitive endoderm. A-iPSCs with  
 
Act, Wnt and exosomes from decellularized distal pig lung, B-iPSCs with Act and 
Wnt, C- iPSCs in E8 medium and D- the appearance of definitive endoderm cells 
(Cheng et al. 2012).  The scale bar is 200μm for A,B, and C and 100µm for D. 
Act+Wnt+exosomes Act+Wnt 
iPSCs in E8 Definitive endoderm (Cheng et al., 2012) 
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RNA isolated from these cell cultures were of high quality and are shown in Table 10. 
Day RNA concentration 
(μg/ml) 
A260/A280 
day 0 iPSCs 31.4 2.257 
day 6 no exosomes 7.952 2.000 
day 6 with exosomes 3.181 2.100 
 
Table 10: RNA analysis during iPSC differentiation to definitive endoderm 
Automated gel electrophoresis 
Although most samples had detectable amounts of RNA by spectrophotometry, the Bioanalyzer 
could not detect any amount of miRNA. The device can detect as low as 5ng of RNA per 1µl 
sample. Only the day 6 sample not treated with exosomes produced a detectable peak which was 
not in the miRNA region (Figure 22A). It suggests the presence of mRNA in this sample. In 
contrast, the day 6 sample that was treated with exosomes showed no peaks at all (Figure 22B) 
which is not surprising as the RNA concentration (Table 10) was below the detectable amount of 
the Bioanalyzer. Cell culture samples with undifferentiated iPSCs grown on E8 did not give a 
high yield of RNA. This can be attributed to poor RNA isolation technique. 
qRT-PCR for cell culture samples at day 6 showed no detectable expression of mature lung or 
definitive endoderm markers (Figure 23). Surprisingly, Oct4 was still detected in the cells that 
were culture with exosomes, indicating some retension of pluripotency. However this is only one 
marker and it is not enough to say that these cells remained as iPSCs since their morphology had 
drastically changed (Figure 21). 
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Figure 22A: Day 6 iPSC culture to definitive endoderm without exosomes 
 
Figure 22B: Day 6 iPSC culture to definitive endoderm with exosomes 
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Figure 23: qRT-PCR data for samples from iPSC culture to definitive endoderm. 
All iPSC samples were pooled together and are from day 0. The samples with and 
without exosomes are from day 6 of differentiation. The data percentage variance 
for each sample done in quadruplicate tested for each gene was less than 5% 
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Discussion 
The need for a suitable scale-up method for translational therapy was deemed necessary 
by the huge number of cells required for recellularization of large essential organs. 
Reaching a number in the order of billions with 2D cell culture is very time-consuming 
and costly as many plates and space is needed. Therefore, iPSCs were cultured in stirred-
flask bioreactors and the cells observed for 6 days. Even though the conditions were set 
similar to the 2D culture conditions, iPSCs were depleted in a mere 24 hours. The 
possibilities were determined by metabolite analysis and cell counts. The lactate assay 
showed evidence of significant cell death from day 0 to day 1. Lactate levels increased to 
about 11ng/μl and then plummeted down to 3ng/μl on day 2. The increase from day 0 to 
day 1 could be attributed to the lactate released from the cells during death. Afterwards, 
the lactate levels would decrease as the media was changed every 2 days. Therefore, on 
day 2, there was much less lactate as there were no cells to produce any more of it. 
Lactate levels gradually decreased after day 2 with each media change but nothing in 
comparison to the first drop as most cell death had already taken place and the slow 
decrease in lactate is due to each consecutive media change. The typical lactate level for 
iPS cells in culture is around 2μM (Varum et al., 2011).  The level reached in the 
bioreactor is about 0.12 ng/μl which is equivalent to 0.12μM. The iPSCs did not even 
reach the lactate levels expected therefore it is likely that a lot of cell death occurred even 
before day 1 was over so that some metabolism took place but could not proceed due to 
cell depletion.  
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The glucose assay showed an initial level of glucose that is much lower than the 
characteristic glucose concentration in serum-free media such as mTESR1, just after the 
cells were transferred to the bioreactor. mTESR™1 medium is known to contain about 
2.466 mg/ml glucose so this value was too low. This may be attributed to the fact that 
cells were under stress because they had already been growing in mTESR1 on the plates. 
The glucose value had increased significantly by day 2. This is inaccurate since cells are 
unable to produce glucose and it is important to state that is higher than the glucose 
concentration of mTESR1 itself. It is said that pluripotent stem cell types such as iPSCs 
and ESCs use anaerobic glycolysis as their major metabolic pathway (Madonna et al. 
2013). This is due to the hypoxic conditions that stem cells normally encounter in the 
niche and is their natural metabolism. As oxygen levels were low in the bioreactor, it is 
likely the cells were responding to this by carrying out glycolysis, which explains the low 
glucose and high lactate levels observed on day 4. Glycolysis splits a glucose molecule 
into two pyruvate molecules which does not require oxygen therefore glucose levels will 
be high in the initial days of iPSC culture, such as day 2. As the cells adapt to the hypoxic 
conditions, they start using glucose for aerobic respiration which may also be the reason 
for the decrease in glucose on day 4. 
The initial decrease in cell number is what is expected in the transition process from 2D 
to 3D culture. The cells need the time to adjust to low oxygen levels. This explains the 
recovery at day 4. The subsequent continuous decrease in cell number until complete 
depletion may be due to lack of an appropriate matrix to support cell attachment. Even 
though the ROCK inhibitor was used in these cultures, it was not able to compensate for 
the lack of a matrix (Chen et al., 2013). It is also possible that the bleach used to clean the 
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apparatus after each experiment could have remained in the crevices of the bioreactor lid. 
This may have caused the sudden cell death observed in many other trials of this 3D cell 
culture. Perhaps a supporting matrix such as collagen-coated beads would be a suitable 
alternative for future experiments.  
The ROCK inhibitor is said to increase embryonic stem cell (ESC) survival by 
attenuating dissociation-induced apoptosis (Watanabe et. al 2007). Further work has 
shown that this survival-promoting effect is evident in the first half-day of cell culture as 
no changes were observed in subsequent days of cell culture (Watanabe et al. 2007). For 
this reason, the ROCK inhibitor was added to the bioreactor culture in the hope that it 
would improve iPSC survival during the transfer from the six-well plates to the stirred-
flask bioreactor. The effect of the molecule was also tested in serum-free culture and the 
results showed that it made no difference to cell survival (Watanabe et al. 2007). In 
addition, the ROCK inhibitor does not affect ESC differentiation in suspension culture 
(Watanabe et al., 2007), which opens the possibility of utilizing this molecule in iPSC 
differentiation to endoderm. Although that particular study (Watanabe et al., 2007) 
focused on ESC culture, other studies have demonstrated the effectiveness of this 
molecule in iPSC suspension culture as well (Larijani et al., 2011, Shafa et al, Olmer et 
al. 2012, Kehoe et al. 2010). It is important to mention the potential of the ROCK 
inhibitor not only in pluripotent cell culture but also in other cell cultures such as the 
many cell types of the lung. Indeed, airway epithelial cell proliferation is improved by 
addition of ROCK inhibitor but not their differentiation to mucous or ciliated cells 
(Horani et al. 2013). The implications of this study are that the ROCK inhibitor could be 
utilized in maintenance of endoderm progenitor cells. There are many conditions in 3D 
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suspension culture that could have caused the massive cell death observed here. The 
oxygen and carbon dioxide levels were at standard levels used in pluripotent stem cell 
culture as were the incubator temperature and humidity. The possibility that the lack of 
some sort of support or platform for the cells was the cause of death may be the answer. 
However, this cannot be the sole reason as many studies have been successful in iPSC 
serum-free suspension culture without any matrix support (Larijani et al., 2011, Shafa et 
al, Olmer et al. 2012, Kehoe et al. 2010). Microcarriers are a very suitable matrix for 
pluripotent stem cell culture in suspension as they give the cell the support they need 
during the transition from the plates to the bioreactor. The conventional method is to coat 
these microcarriers with extracellular matrix material such as Matrigel. Many ECM 
materials come from animal sources, which would ideally not be a translatable clinical 
therapy. One such study linked the benefits of the ROCK inhibitor with microcarriers by 
culturing the cells with ROCK on microcarriers with and without ECM coating (Chen et 
al. 2013). The end result was that ROCK was able to replace the role of the ECM coating 
by promoting cell survival (Chen et al. 2013). It is a desirable alternative to culturing 
cells with animal matrices such as Matrigel.  
Exosomes 
RNA concentration measurements in exosome preparations indicated variability in RNA 
quality. Abnormally high concentrations of RNA with a low A260/A280 ratio are usually 
due to the presence of contaminants such as proteins. The differences in RNA 
concentration could be attributed to technical inexperience since the quality improved as 
more samples were processed. 
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Automated RNA electrophoresis 
Normal lung samples gave very tall, sharp peaks of similar size, regardless of species. 
This indicates that miRNAs among species must be similar in structure to produce 
fluorescence peaks at the exact same time. The typical miRNA region on these spectra is 
said to be between 10 and 40 seconds (Becker et al 2010). All of the peaks for normal 
lungs appear within this region which confirms the presence of miRNAs. This is the 
result typically expected of normal lungs as they contain cells and therefore many 
exosomes in the intracellular and extracellular environment. The mouse, pig distal and 
small airway samples also had a smaller hump appear right after the prominent, large 
peak which is still within the miRNA region. These may be longer miRNA sequences as 
the larger the molecular weight, the later they will appear in the spectra. These smaller 
humps did not appear in the normal large airway spectrum. Any sharp, prominent peaks 
after 40 seconds would typically represent tRNAs if between 50 and 80 seconds and 
small rRNAs if between 80 and 150 seconds. None of the spectra for normal lung 
samples displayed these features. The main RNA component of exosomes is miRNA so it 
is an indication of good exosome isolation to only see miRNA even though this miRNA 
may not only be from the exosomes themselves. It is also possible that there may be 
residual miRNA or fragmented mRNA from the tissue. When mRNA is degraded it will 
have shorter sequences so the instrument will detect this as short sequence RNA which 
will appear in the miRNA region. Therefore, the small humps mentioned earlier may be 
some degraded mRNA leftover from the exosome isolation process. As a result, the 
instrument may overestimate the amount of miRNA and this method of automated gel 
electrophoresis may only be accurate for RNA samples of very high quality. Although the 
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RNA from these normal lung samples were of very high quality, a part of the miRNA 
region will represent a number of undefined small RNA fragments and this is 
unavoidable as it is expected to have a minimal amount of RNA degradation during RNA 
isolation and loading of the chip for electrophoresis. Current methods cannot guarantee 
isolation of pure miRNA. The only way to identify miRNA is to proceed to real-time RT-
PCR using assays for several miRNAs that are expected to be in the samples.  All 
eukaryotic cells possess ribosomal RNAs 18S and 28S that typically appear as very tall 
and sharp peaks at 43 and 49 seconds respectively. Both of these components were absent 
from the spectra in all normal lung exosome samples. This is another good feature of 
successful exosome isolation as no cells should remain after the process and hence no 
ribosomal RNA. The RNA quality index measures the amount of 28S ribosomal RNA to 
the amount of 18S ribosomal RNA to generate a ratio as means to determine RNA 
quality. The 28S rRNA degrades much more quickly than the 18S rRNA so a ratio of 10 
would indicate high quality RNA with minimal degradation. However, this ratio can only 
be generated in cellular RNA samples as exosomes do not contain ribosomal RNA. 
Nevertheless, most of the exosomal RNA samples had an RQI, albeit at low values. The 
anomalies, normal mouse lung and decellularized pig large airway from batch 2, possibly 
did not undergo successful exosome isolation or were contaminated during the RNA 
isolation or well loading procedures. Even the wells with DEPC-treated water had an RQI 
which could explain the RQI of the lung samples although it could be a combination of 
contamination of the DEPC-treated water and contamination of the sample with cellular 
i.e. ribosomal RNA. It is also possible that the automated electrophoresis machine is 
contaminated. The only way to overcome this would be to carry out the ‘deep clean’ 
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procedure by cleaning the electrodes in the machine with probe wipes. Even though the 
routine cleaning before and after every experiment reduces the chances of contamination, 
the ‘deep clean’ procedure should be carried out after extended use. 
The first set of decellularized lungs displayed no signs of rRNA either which also implies 
successful exosome isolation for these samples. The decellularized mouse lung gave no 
indication of any type of RNA despite the 8.748μg/ml that appeared in the Implen 
Nanophotometer. This may be due to the poor A260/A280 ratio which gave a false high 
of RNA amount. The same applied for the decellularized mouse lung from the second set. 
This correlates with real-time RT-PCR results since no relative expression of any of the 
Taqman probes tested was found. Decellularized distal pig lung samples showed a 
significant amount of RNA. The higher peak in the former may be due to an 
overestimation of RNA as the RNA isolated from the first set of decellularized samples 
was not very pure. In contrast, the second set was reasonably pure which is evident from 
the higher A260/A280 ratio. The decellularized pig small airway showed a higher peak in 
the second batch compared to the first. In this case, a higher peak may have appeared in 
the second set as the RNA was more pure and may have been underestimated in the first 
set. DEPC-water samples did not have any peaks except for the lower marker. This 
confirms the fact that the DEPC-treated water used in the wells with the samples was 
indeed not contaminated. The virtual gels generated by the instrument accurately 
displayed the approximate RNA molecular weight range and purity. Some faint bands 
were seen that were too high for the miRNA region, which appears between 200-500 
nucleotides. This, again, may indicate the presence of degraded RNA which is displayed 
in the spectrum as a large peak in the miRNA region. As this is the first of decellularized 
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lungs the results do not have to be depended on, as the RNA purity was low in this case. 
The second set of decellularized lung samples give a much more accurate and precise 
estimation of miRNA content as their RNA was very pure. It is not to say that 
decellularized pig distal lung did not contain miRNA but rather that the amount is 
overestimated in the first set. Furthermore, the first electrophoresis experiment results 
cannot be completely relied on as the decellularized mouse, pig small airway and large 
airway samples showed peaks reduced to negative fluorescence units which is possibly 
due to pipetting errors while the wells were being filled with sample. This was improved 
when the samples were run a second time when smaller peaks appeared which accurately 
demonstrated miRNA content. Therefore, it is safe to say that all normal lung and 
decellularized pig distal lung samples had significant amounts of RNA.  
qRT-PCR data showed that normal mouse lung expressed all tested miRNA with miR15a 
being the highest, followed by miR375, miR29b and a minimal amount of miR29c. 
MiR15a was significant because it had a relative quantity of 0.45 which means it 
expressed 45% of the amount of normal pig distal lung. MiRNAs are subjects of recent 
research so many of them have unknown or not clear-cut functions. Most studies have 
focused on the effects of their deletion or overexpression. miR15a is said to be involved 
in cell cycle control and apoptosis (Bandi et al. 2010). Their deletion has been associated 
with the increase in cyclin D1 which results in hyperproliferation of cells in the lung 
leading to adenocarcinomas and squamous cell carcinomas.  
The miR29 family of miRNAs are normally expressed in lungs of adult pig and mouse, 
specifically in the alveolar wall and pleura and in mesenchymal cells at entrance of the 
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alveolar duct (Cushing et al., 2011). In regards to qRT-PCR data, the relative quantity of 
miR29b was quite low for normal mouse lung compared to miR29c. It could be that 
miR29b is normally expressed at low levels in normal adult mouse lung to maintain 
essential cellular processes but is still fundamental for proper lung function. Cushing et 
al. also studied changes in miR29 levels over the course of mouse development. MiR29 
levels gradually increased from as early as the embryonic stage, becoming the highest in 
adult lung. This stresses the importance of miR29 in development and suggests a role in 
alveolar development. MiR29 levels could be a useful determinant of stem cell 
differentiation stage in the developing lung.  As stated previously, the functions of 
miRNAs are mainly determined by observation after deletion or exploring their 
therapeutic potential through overexpression or exogenous delivery. Downregulation of 
miR29 is observed in pulmonary fibrosis models (Cushing et al 2011) and is associated 
with up-regulation of pro-fibrotic target genes. Moreover, the expression levels of miR29 
decreased with the severity of the disease and the pro-fibrotic genes increased. It can be 
seen that the miR29 family is essential for maintenance of normal lung structure by 
regulating ECM deposition and remodeling.  
MiRNAs also play a critical role in cell signaling mechanisms. For instance, it was found 
that the miR29 family of miRNAs are downstream targets of the TGF-β-Smad3 signaling 
pathway. As many ECM proteins are target genes of miR29, it is highly associated with 
the fibrosis of many organs such as lung , liver and heart. Indeed, studies on bleomycin-
induced Smad3 knockout mice versus bleomycin-induced wild type mice have shown 
that the downregulation of miR29, along with the emergence of fibrosis is Smad3-
dependent (Xiao et al. 2012). This demonstrates the importance of miRNAs in essential 
77 
 
cell processes and their potential future role in cell therapy. The same study used ectopic 
expression of miR29b to improve the condition of bleomycin-induced pulmonary fibrosis 
in mice by blocking progressive fibrosis. Fibrosis is caused by activation of fibroblasts in 
the lung that thicken around the alveoli and cause scarring and is caused by many 
environmental factors such as asbestos. Therefore, the existence of miR29b and miR29c 
in the decellularized mouse lung would be advantageous when iPSCs or endodermal 
progenitor cells are injected into the lung because they would prevent potential fibrosis if 
a particular patient is prone to these fibrotic factors. This goes back to the concept of the 
preservation of the ECM in decellularized matrices and the molecular cues needed for 
correct regeneration.  
Mir375 was expressed 0.3 times the quantity of normal pig distal lung. Pigs have much 
larger lungs therefore decellularization would be more challenging compared to mouse 
lungs, especially the distal parts of the lung. Therefore, it is not a surprise that a 
significant amount of miR375 remained in decellularized distal pig lung as opposed to 
none in the decellularized mouse lung. Mir375 expression starts to increase upon 
differentiation to definitive endoderm and then gradually decreases upon further 
differentiation to pulmonary or hepatic cells (Wei et al. 2013). In that particular study, 
embryonic stem cells were differentiated to insulin-producing cells via differentiation to 
definitive endoderm first. The results showed increased expression of miR375 upon 
formation of definitive endoderm and started decreasing once the pancreatic progenitors 
were formed. This demonstrates the significance of miR375 as a good marker of 
definitive endoderm. Even though slightly more mature cells such as pancreatic 
progenitors express this miRNA, it will be useful when checking for definitive endoderm 
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cells during differentiation to pulmonary epithelial cells. Indeed, it is known that miR375 
regulates alveolar epithelial cell (AEC) transdifferentiation (Wang et al, 2013). During 
lung injury, type II pneumocytes trans-differentiate to type I pneumocytes to maintain 
essential lung functions as type I pneumocytes regulate gas exchange and fluid transport. 
MiR375 expression gradually decreases during AEC trans-differentiation and is enriched 
in type II pneumocytes (Wang et al. 2013). Over-expression of miR375 resulted in 
inhibition of AEC transdifferentiation. This may explain the detection of miR375 in 
normal mouse lung. It is still a surprise to discover the important role miR375 has in the 
developing and injured lung because it is firmly established that this miRNA determines 
islet development in the pancreas (Li, 2014). This is probably due to the fact that miR375 
is highly conserved among many species and was first cloned from a pancreatic cell line. 
The link between miR375 and the lung is fairly new so its various roles are yet to be 
determined. As mentioned above, miR375 is expressed early in development. As its 
levels are high at the definitive endoderm stage, miR375 has an even broader set of 
functions than first thought. This would be useful from our perspective as this miRNA 
could be used to direct the differentiation of iPSCs or endodermal progenitor cells that 
are injected into the decellularized lung. Stem cell differentiation to various progeny 
occurs via inactivation of transcriptional repressors. It is these repressors that keep stem 
cells in their pluripotent state. One of the ways these repressors can get inactivated is by 
miRNA silencing, leading the way to differentiation. It was also mentioned in the 
introduction that differential expression of miRNAs are implicated in several types of 
cancer. Levels of miR375 tend to decrease in cells affected by non-small-cell lung 
cancer, suggesting a tumor suppressor function for this miRNA (Yu et al, 2014). 
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Therefore, not only will miRNAs be used as indicators of development and regeneration, 
but also as disease markers. 
MiR15a is robustly expressed in both adult pig and mouse lungs. The precise role of 
miR15a in lung development is unknown however functions have been speculated from 
its down-regulation in non-small-cell lung cancer (Bandi et al., 2009). In this particular 
disease, cyclin D1 is upregulated and seems to correlate with the down-regulation of 
miR15a, suggesting it to be a likely target of this miRNA. It was demonstrated that 
miR15a induced cell-cycle arrest and non-small-cell lung cancer cells escape this cell 
cycle arrest because miR15a is down-regulated (Bandi et al., 2009). In terms of lung 
development and regeneration, it could be stated that all healthy adult pig and mouse 
lungs should have more than a detectable amount of miR15a expression. This is obvious 
in the qRT-PCR results for normal mouse lung which is expected as total lung was used. 
It is also evident in the normal pig distal lung, small airway and to a much smaller degree 
in the large airway. Perhaps miR15a is expressed in the squamous tissue of the lung itself 
rather than the harder cartilage of the airway. 
iPSC differentiation to definitive endoderm 
The iPSCs treated with Activin and Wnt appeared very similar to the iPSCs maintained in 
Essential 8 medium. Many protocols have been created for the differentiation to 
definitive endoderm which utilize Activin, Wnt and many other factors such as basal 
fibroblast growth factor (bFGF). According to the results above, this does not hold true 
for the iPSCs used in this experiment. Every iPSC line retains epigenetic memory from 
the type of cell it was reprogrammed from (Kim et al., 2010). Therefore, each line is 
80 
 
unique and can behave differently because the chromatin structure in the iPSC nucleus 
varies in structure and organization. The transcription factors used in the differentiation 
protocol will interact with the DNA in the iPSCs in an independent fashion in each cell 
line. This could be a reason for not obtaining definitive endoderm cells. In addition, it is 
said that miRNAs contribute to iPSCs-somatic donor memory (Vitaloni et al., 2013).This 
was analyzed in iPSCs derived from cord blood which were compared to hematopoietic 
progenitor cells (HPCs) differentiated from these iPSCs. MiRNA microarrays were done 
for both from low-passage iPSCs and high-passage iPSCs derived from HPCs in the cord 
blood. Interestingly, the low-passage iPSCs retained miRNA expression characteristic of 
HPCs in comparison to their high-passage counterparts. The iPSCs obtained for this cell 
culture experiment had been re-programmed from bone marrow fibroblasts therefore it is 
only logical that these cells retain epigenetic and possibly miRNA memory. According to 
Vitaloni et al., iPSCs would be considered low-passage if they had undergone 10 
passages or less however the iPSCs used in this experiment were passage 14. There is no 
clear-cut borderline for these characteristics so it is enough to consider the possibility that 
these iPSCs had memory of their bone marrow origin. If this were true, the epigenetic 
and miRNA memories of these iPSCs may be a barrier to their differentiation to 
definitive endoderm. 
  In stark contrast, the iPSCs that received exosomes from decellularized pig distal lung 
as well as Activin and Wnt exhibited completely different morphology. They appeared to 
form clusters of cells, some of them being ring-shaped. This is indicative of definitive 
endoderm but cannot be confirmed without information from real-time PCR data.  
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In conclusion, exosomes were shown to remain in pig and mouse lungs, even after 
decellularization. They contain significant amounts of miRNA that can be used to alter 
the course of iPSC differentiation to definitive endoderm. Even though large-scale culture 
was not successful, this method still has great potential in generating large numbers of 
cells for recellularization. This may help the recellularization process of the pig lung in 
the long run. It may also be translatable to the clinic when the correct number and types 
of cells have been generated and successfully reconstitute decellularized pig lung matrix. 
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